Alerts will be sent to your verified email
Verify EmailMEDICAMEQ
|
Medicamen Biotech
|
Medico Remedies
|
Shivalik Rasayan
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
6.92 % | 13.93 % | 6.54 % |
|
5yr average Equity Multiplier
|
1.44 | 2.07 | 1.82 |
|
5yr Average Asset Turnover Ratio
|
0.55 | 1.49 | 0.44 |
|
5yr Avg Net Profit Margin
|
8.69 % | 4.73 % | 7.94 % |
|
Price to Book
|
1.35 | 5.19 | 0.7 |
|
P/E
|
39.54 | 29.94 | 35.85 |
|
5yr Avg Cash Conversion Cycle
|
49.75 Days | 53.33 Days | 100.7 Days |
|
Inventory Days
|
84.58 Days | 48.95 Days | 80.64 Days |
|
Days Receivable
|
139.4 Days | 129.15 Days | 107.04 Days |
|
Days Payable
|
264.75 Days | 124.28 Days | 166.18 Days |
|
5yr Average Interest Coverage Ratio
|
7.03 | 11.55 | 8.55 |
|
5yr Avg ROCE
|
10.34 % | 20.03 % | 8.54 % |
|
5yr Avg Operating Profit Margin
|
15.51 % | 7.11 % | 17.6 % |
|
5 yr average Debt to Equity
|
0.15 | 0.26 | 0.2 |
|
5yr CAGR Net Profit
|
-11.57 % | 31.26 % | -1.04 % |
|
5yr Average Return on Assets
|
4.73 % | 6.88 % | 3.57 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
40.46 % | 61.38 % | 47.37 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.75 % | -11.96 % | -2.95 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Medicamen Biotech
|
Medico Remedies
|
Shivalik Rasayan
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|